Copyright Reports & Markets. All rights reserved.

Global and United States Insomnia Pharmacological Treatment Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Insomnia Pharmacological Treatment Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Prescription Sleep Aids
    • 1.2.3 Over-the-Counter Sleep Aids
  • 1.3 Market by Application
    • 1.3.1 Global Insomnia Pharmacological Treatment Market Share by Application: 2020 VS 2026
    • 1.3.2 Homecare
    • 1.3.3 Clinic
    • 1.3.4 Hospital
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Insomnia Pharmacological Treatment Market Perspective (2015-2026)
  • 2.2 Global Insomnia Pharmacological Treatment Growth Trends by Regions
    • 2.2.1 Insomnia Pharmacological Treatment Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Insomnia Pharmacological Treatment Historic Market Share by Regions (2015-2020)
    • 2.2.3 Insomnia Pharmacological Treatment Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Insomnia Pharmacological Treatment Players by Market Size
    • 3.1.1 Global Top Insomnia Pharmacological Treatment Players by Revenue (2015-2020)
    • 3.1.2 Global Insomnia Pharmacological Treatment Revenue Market Share by Players (2015-2020)
  • 3.2 Global Insomnia Pharmacological Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Insomnia Pharmacological Treatment Revenue
  • 3.4 Global Insomnia Pharmacological Treatment Market Concentration Ratio
    • 3.4.1 Global Insomnia Pharmacological Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Insomnia Pharmacological Treatment Revenue in 2019
  • 3.5 Key Players Insomnia Pharmacological Treatment Area Served
  • 3.6 Key Players Insomnia Pharmacological Treatment Product Solution and Service
  • 3.7 Date of Enter into Insomnia Pharmacological Treatment Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Insomnia Pharmacological Treatment Breakdown Data by Type (2015-2026)

  • 4.1 Global Insomnia Pharmacological Treatment Historic Market Size by Type (2015-2020)
  • 4.2 Global Insomnia Pharmacological Treatment Forecasted Market Size by Type (2021-2026)

5 Insomnia Pharmacological Treatment Breakdown Data by Application (2015-2026)

  • 5.1 Global Insomnia Pharmacological Treatment Historic Market Size by Application (2015-2020)
  • 5.2 Global Insomnia Pharmacological Treatment Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Insomnia Pharmacological Treatment Market Size (2015-2026)
  • 6.2 North America Insomnia Pharmacological Treatment Market Size by Type (2015-2020)
  • 6.3 North America Insomnia Pharmacological Treatment Market Size by Application (2015-2020)
  • 6.4 North America Insomnia Pharmacological Treatment Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Insomnia Pharmacological Treatment Market Size (2015-2026)
  • 7.2 Europe Insomnia Pharmacological Treatment Market Size by Type (2015-2020)
  • 7.3 Europe Insomnia Pharmacological Treatment Market Size by Application (2015-2020)
  • 7.4 Europe Insomnia Pharmacological Treatment Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Insomnia Pharmacological Treatment Market Size (2015-2026)
  • 8.2 China Insomnia Pharmacological Treatment Market Size by Type (2015-2020)
  • 8.3 China Insomnia Pharmacological Treatment Market Size by Application (2015-2020)
  • 8.4 China Insomnia Pharmacological Treatment Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Insomnia Pharmacological Treatment Market Size (2015-2026)
  • 9.2 Japan Insomnia Pharmacological Treatment Market Size by Type (2015-2020)
  • 9.3 Japan Insomnia Pharmacological Treatment Market Size by Application (2015-2020)
  • 9.4 Japan Insomnia Pharmacological Treatment Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Insomnia Pharmacological Treatment Market Size (2015-2026)
  • 10.2 Southeast Asia Insomnia Pharmacological Treatment Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Insomnia Pharmacological Treatment Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Insomnia Pharmacological Treatment Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Eisai, Co. Ltd. (Japan)
    • 11.1.1 Eisai, Co. Ltd. (Japan) Company Details
    • 11.1.2 Eisai, Co. Ltd. (Japan) Business Overview
    • 11.1.3 Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Introduction
    • 11.1.4 Eisai, Co. Ltd. (Japan) Revenue in Insomnia Pharmacological Treatment Business (2015-2020))
    • 11.1.5 Eisai, Co. Ltd. (Japan) Recent Development
  • 11.2 Merck & Co., Inc. (U.S.)
    • 11.2.1 Merck & Co., Inc. (U.S.) Company Details
    • 11.2.2 Merck & Co., Inc. (U.S.) Business Overview
    • 11.2.3 Merck & Co., Inc. (U.S.) Insomnia Pharmacological Treatment Introduction
    • 11.2.4 Merck & Co., Inc. (U.S.) Revenue in Insomnia Pharmacological Treatment Business (2015-2020)
    • 11.2.5 Merck & Co., Inc. (U.S.) Recent Development
  • 11.3 Meda Consumer Healthcare Inc. (U.S.)
    • 11.3.1 Meda Consumer Healthcare Inc. (U.S.) Company Details
    • 11.3.2 Meda Consumer Healthcare Inc. (U.S.) Business Overview
    • 11.3.3 Meda Consumer Healthcare Inc. (U.S.) Insomnia Pharmacological Treatment Introduction
    • 11.3.4 Meda Consumer Healthcare Inc. (U.S.) Revenue in Insomnia Pharmacological Treatment Business (2015-2020)
    • 11.3.5 Meda Consumer Healthcare Inc. (U.S.) Recent Development
  • 11.4 Pfizer, Inc. (U.S.)
    • 11.4.1 Pfizer, Inc. (U.S.) Company Details
    • 11.4.2 Pfizer, Inc. (U.S.) Business Overview
    • 11.4.3 Pfizer, Inc. (U.S.) Insomnia Pharmacological Treatment Introduction
    • 11.4.4 Pfizer, Inc. (U.S.) Revenue in Insomnia Pharmacological Treatment Business (2015-2020)
    • 11.4.5 Pfizer, Inc. (U.S.) Recent Development
  • 11.5 Sanofi (France)
    • 11.5.1 Sanofi (France) Company Details
    • 11.5.2 Sanofi (France) Business Overview
    • 11.5.3 Sanofi (France) Insomnia Pharmacological Treatment Introduction
    • 11.5.4 Sanofi (France) Revenue in Insomnia Pharmacological Treatment Business (2015-2020)
    • 11.5.5 Sanofi (France) Recent Development
  • 11.6 Takeda Pharmaceutical Company Ltd. (Japan)
    • 11.6.1 Takeda Pharmaceutical Company Ltd. (Japan) Company Details
    • 11.6.2 Takeda Pharmaceutical Company Ltd. (Japan) Business Overview
    • 11.6.3 Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Introduction
    • 11.6.4 Takeda Pharmaceutical Company Ltd. (Japan) Revenue in Insomnia Pharmacological Treatment Business (2015-2020)
    • 11.6.5 Takeda Pharmaceutical Company Ltd. (Japan) Recent Development
  • 11.7 Pernix Therapeutics (U.S.)
    • 11.7.1 Pernix Therapeutics (U.S.) Company Details
    • 11.7.2 Pernix Therapeutics (U.S.) Business Overview
    • 11.7.3 Pernix Therapeutics (U.S.) Insomnia Pharmacological Treatment Introduction
    • 11.7.4 Pernix Therapeutics (U.S.) Revenue in Insomnia Pharmacological Treatment Business (2015-2020)
    • 11.7.5 Pernix Therapeutics (U.S.) Recent Development
  • 11.8 Purdue Pharma L.P. (U.S.)
    • 11.8.1 Purdue Pharma L.P. (U.S.) Company Details
    • 11.8.2 Purdue Pharma L.P. (U.S.) Business Overview
    • 11.8.3 Purdue Pharma L.P. (U.S.) Insomnia Pharmacological Treatment Introduction
    • 11.8.4 Purdue Pharma L.P. (U.S.) Revenue in Insomnia Pharmacological Treatment Business (2015-2020)
    • 11.8.5 Purdue Pharma L.P. (U.S.) Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Insomnia Pharmacological Treatment Scope and Market Size
    Insomnia Pharmacological Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Insomnia Pharmacological Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Prescription Sleep Aids
    Over-the-Counter Sleep Aids

    Market segment by Application, split into
    Homecare
    Clinic
    Hospital

    Based on regional and country-level analysis, the Insomnia Pharmacological Treatment market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Insomnia Pharmacological Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Eisai, Co. Ltd. (Japan)
    Merck & Co., Inc. (U.S.)
    Meda Consumer Healthcare Inc. (U.S.)
    Pfizer, Inc. (U.S.)
    Sanofi (France)
    Takeda Pharmaceutical Company Ltd. (Japan)
    Pernix Therapeutics (U.S.)
    Purdue Pharma L.P. (U.S.)

    Buy now